Clinical

Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
 
Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
 
Read More

Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
 
Learn More

Luminex® Blog

The Faces of Luminex: Stephen Angeloni, Field Applications

Maybe you’ve come up with a great new idea for a multiplex assay, but you need some assistance optimizing the reagents. Or perhaps you just want some training in assay design to streamline internal development. When it comes to helping customers make the most of their xMAP® Technology, Stephen Angeloni is there. As a Maryland-based Senior Field Application Scientist, he works closely with customers to make sure their assays run as smoothly as possible. He earned his PhD in biochemistry from Virginia Tech and has been with Luminex since 2011.

Continue Reading >

xMAP® Technology Overview

 
Luminex xMAP® Technology Overview

 

xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.

Watch more videos >

Luminex on Twitter


The Luminex Toronto team participated in the @BreastCancerCCS #CIBCRunfortheCure, and raised more than $1,700 for t… https://t.co/IOmJNBjpIs
h J R
The #ARIES #Flu A/B & #RSV assay is an easy and effective way to rapidly test for #respiratory illnesses. But don't… https://t.co/PmYWkDuTAl
h J R

Latest News

October 18
Luminex Corporation to Acquire MilliporeSigma’s Flow Cytometry Portfolio

October 15
Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2018

September 11
Luminex Corporation Declares Third Quarter Cash Dividend

September 6
Luminex Corporation to Present at the Morgan Stanley 16th Annual Global Healthcare Conference

August 6
Luminex Corporation Reports Second Quarter 2018 Financial Results

Events

World Vaccine Congress
29-31 October
Lisbon, Portugal

xMAP® Connect Amsterdam
6-7 November
Amsterdam, Netherlands